The Efficacy and Safety of Entecavir and Interferon Combination Therapy for Chronic Hepatitis B Virus Infection: A Meta-Analysis

Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy

(2015) Patrick Marcellin et al.   JOURNAL OF HEPATOLOGY

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

(2015)   JOURNAL OF HEPATOLOGY

Off-treatment virologic relapse and outcomes of re-treatment in chronic hepatitis B patients who achieved complete viral suppression with oral nucleos(t)ide analogs

(2014) Hyung Rae Sohn et al.   BMC INFECTIOUS DISEASES

A Randomized, Open-Label Clinical Study of Combined Pegylated Interferon Alfa-2a (40KD) and Entecavir Treatment for Hepatitis B "e" Antigen-Positive Chronic Hepatitis B

(2014) Q. Xie et al.   CLINICAL INFECTIOUS DISEASES

Interferon Therapy of Chronic Hepatitis B

(2014) Maurizia Rossana Brunetto et al.   INTERVIROLOGY

Comparison of Efficacy and Safety of Tenofovir and Entecavir in Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-Analysis

(2014) Weixia Ke et al.   PLoS One

Management of chronic hepatitis B infection: Current treatment guidelines, challenges, and new developments

(2014) Ceen-Ming Tang   WORLD JOURNAL OF GASTROENTEROLOGY

Combination therapy with a nucleos(t)ide analogue and interferon for chronic hepatitis B: simultaneous or sequential

(2013) Masaru Enomoto et al.   JOURNAL OF GASTROENTEROLOGY

Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes

(2013) L. Boglione et al.   JOURNAL OF VIRAL HEPATITIS

Relapse rates in chronic hepatitis B naïve patients after discontinuation of antiviral therapy with entecavir

(2013) E. Ridruejo et al.   JOURNAL OF VIRAL HEPATITIS

HBeAg-positive chronic hepatitis B: Why do I treat my patients with Nucleos(t)ide Analogs?

(2013) Maria Buti   LIVER INTERNATIONAL

Recent Advances in the Management of Chronic Hepatitis B

(2012) Soo Ryang Kim et al.   Hepatitis Monthly

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

(2012) Yun-Fan Liaw et al.   Hepatology International

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

(2012) Patrick Marcellin et al.   LANCET

Safety and efficacy of two-step peginterferon α-2a treatment in patients of chronic hepatitis B with acute exacerbation

(2011) C.-C. Chen et al.   JOURNAL OF VIRAL HEPATITIS

A Review of Oral Antiretroviral Therapy for the Treatment of Chronic Hepatitis B

(2010) Lauren M Hynicka et al.   ANNALS OF PHARMACOTHERAPY

Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan

(2010) Hiromitsu Kumada et al.   HEPATOLOGY RESEARCH

Chronic hepatitis B: Update 2009

(2009) Anna S. F. Lok et al.   HEPATOLOGY

Hepatitis B virus infection

(2009) Yun-Fan Liaw et al.   LANCET

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

EASL Clinical Practice Guidelines: Management of chronic hepatitis B

(2008)   JOURNAL OF HEPATOLOGY

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

(2008) Lesley Wood et al.   BMJ-British Medical Journal